Please use this identifier to cite or link to this item:
|Title:||Postgenomics of Neisseria meningitidis for vaccines development||Authors:||Bernardini, Giulia
|Issue Date:||2007||Project:||None||Journal:||EXPERT REVIEW OF PROTEOMICS||Abstract:||
Neisseria meningitidis infection still remains a major life-threatening bacterial disease worldwide. The availability of bacterial genomic sequences generated a paradigm shift in microbiological and vaccines sciences, and post-genomics (comparative genomics, functional genomics, proteomics and a combination/evolution of these techniques) played important roles in elucidating bacterial biological complexity and pathogenic traits, at the same time accelerating the development of therapeutic drugs and vaccines. This article summarizes the most recent technological and scientific advances in meningococcal biology and pathogenesis aimed at the development and characterization of vaccines against the pathogenic meningococci.
|Appears in Collections:||Publications|
Show full item record
checked on May 5, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.